Cart
sales@molnova.com
Iridin
CAS No. 491-74-7
Iridin( —— )
Catalog No. M18647 CAS No. 491-74-7
Iridin is major active ingredient of Iris dichotoma which could be used as the drug for pain, inflammation treatment.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 40 | In Stock |
|
| 10MG | 32 | In Stock |
|
| 25MG | 51 | In Stock |
|
| 50MG | 73 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIridin
-
NoteResearch use only, not for human use.
-
Brief DescriptionIridin is major active ingredient of Iris dichotoma which could be used as the drug for pain, inflammation treatment.
-
DescriptionIridin is major active ingredient of Iris dichotoma which could be used as the drug for pain, inflammation treatment.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number491-74-7
-
Formula Weight522.46
-
Molecular FormulaC24H26O13
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (191.40 mM)
-
SMILESCOc1cc(cc(c1OC)O)c1coc2cc(c(c(c2c1=O)O)OC)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PF-956980
A potent, highly specific JAK3 inhibitor with IC50 of 4 nM; shows only modest inhibition of PKA (6.7 uM) and LCK (10.9 uM) in vitro.
-
S-Ruxolitinib
Ruxolitinib (INCB018424) is the first potent selective JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays.
-
JAK2-IN-7
JAK2-IN-7 is a selective JAK2 inhibitor with IC50s of 3, 11.7, and 41 nM for JAK2, SET-2, and Ba/F3V617F cells, respectively. JAK2-IN-7 possesses >14-fold selectivity over JAK1, JAK3, FLT3. JAK2-IN-7 stimulates cell cycle arrest in the G0/G1 phase and induces tumor cellapoptosis. Antitumor activities.
